Recalled Eye Drops May Not Be Sterile, Affecting Local Area
Eye drops sold under several brand names have been recalled in the Orlando-Daytona Beach-Melbourne area because they may not be sterile.
Orlando Daytona Beach Melbourne, FL, October 3, 2026 — A recall has been issued for several brands of eye drops due to potential contamination, with the affected products available in the Orlando-Daytona Beach-Melbourne area. The primary concern cited for the recall is that the eye drops may not be sterile, posing a risk to users.
The specific brands of eye drops involved in the recall were not detailed in the provided summary. Similarly, the exact reasons or laboratory findings that led to the determination that the products may not be sterile were not specified. Information regarding the timeline of when these products were distributed or sold in the affected region was also not made available.
Consumers who have purchased eye drops are advised to check for recall notices from the manufacturers or regulatory agencies. The potential lack of sterility in eye drops can lead to serious eye infections. Symptoms of such infections can include eye pain, redness, swelling, discharge, or changes in vision. It is important for individuals experiencing any adverse reactions after using eye drops to seek immediate medical attention.
The scope of the recall, including specific lot numbers or manufacturing dates, has not been disclosed. Consumers are encouraged to consult official product recall lists or contact the manufacturers directly for detailed information regarding affected products and guidance on returns or refunds. The contractor responsible for the manufacturing or distribution, if applicable, was not identified in the summary.
Further details regarding the specific brands, manufacturing facilities, or the extent of the distribution network are pending. Health authorities typically issue such recalls to prevent potential harm to public health when products are found to be non-compliant with safety standards, such as sterility requirements for ophthalmic solutions.
Story summarized from the original created by Heather.Miller@fox.com (Heather Miller) on www.fox35orlando.com, see more information here.
Media gallery
